Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study (SelfExPD)

April 12, 2026 updated by: Won-Seok Kim, Seoul National University Hospital
This study aims to test whether patients with Parkinson's disease can safely and effectively use a home-based exercise program guided by videos. Participants will follow video instructions for exercises at home while their movements are monitored by a camera, which provides real-time feedback. The study will check how well participants complete the exercises, their satisfaction with the program, and any changes in clinical function. The goal is to see if this type of home exercise can help patients increase their activity levels without significant side effects.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • South Korea
      • Seongnam-si, South Korea, 13620
        • Seoul National University Bundang Hospital
        • Contact:
          • Won-Seok Kim, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 19 years or older, clinically diagnosed with Idiopathic Parkinson's Disease (PD) according to the Movement Disorder Society (MDS) clinical diagnostic criteria
  • Patients at Hoehn and Yahr stage 1-2.5
  • Patients on stable dopaminergic therapy with no changes in the past 1 month
  • Patients receiving Lee Silverman Voice Treatment (LSVT) rehabilitation therapy once weekly as outpatients
  • Patients who have voluntarily provided informed consent to participate in the study

Exclusion Criteria:

  • Patients diagnosed with atypical parkinsonism
  • Patients with musculoskeletal problems that make participation in rehabilitation difficult
  • Patients who have limited access to the video-based home exercise feedback program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Home-based Exercise Program (Single Arm)
Participants follow a 6-week home-based exercise program guided by instructional videos, including stretching, strength, balance, aerobic, and LSVT-specific exercises. A camera provides real-time feedback using the iPixel exercise feedback system, and participants complete sessions at least 5 times per week, 40 minutes per session, with weekly 30-minute in-person check-ins for monitoring and support.
Behavioral: Home-based self-exercise feedback program using video

Participants follow a 6-week home-based exercise program using video-guided instructions and the iPixel exercise feedback system, which monitors movements in real-time and provides corrective feedback. The program includes: Stretching exercises, Strength training, Balance exercises, Aerobic exercises, LSVT-specific exercises.

Participants are instructed to complete sessions at least 5 times per week, 40 minutes per session. Additionally, weekly 30-minute in-person rehabilitation sessions are conducted to adjust the next week's exercise intensity based on each participant's functional level.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Part III (Motor Examination)
Time Frame: From enrollment to the end of treatment at 6 weeks
0 to 108, with higher scores indicating worse motor function.
From enrollment to the end of treatment at 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Hoehn and Yahr sacle
Time Frame: From enrollment to the end of treatment at 6 weeks
Modified Hoehn and Yahr Scale Score range: 0 to 5, with higher scores indicating more severe disease stage.
From enrollment to the end of treatment at 6 weeks
Berg Balance Scale
Time Frame: From enrollment to the end of treatment at 6 weeks
0 to 56, with higher scores indicating better balance ability.
From enrollment to the end of treatment at 6 weeks
Functional Gait Ability
Time Frame: From enrollment to the end of treatment at 6 weeks
0 to 30, with higher scores indicating better gait function.
From enrollment to the end of treatment at 6 weeks
Freezing of Gait Questionnaire
Time Frame: From enrollment to the end of treatment at 6 weeks
0 to 24, with higher scores indicating more severe freezing of gait.
From enrollment to the end of treatment at 6 weeks
EuroQol-5 Dimention Questionnaire
Time Frame: From enrollment to the end of treatment at 6 weeks
0 to 1, with higher scores indicating better health-related quality of life.
From enrollment to the end of treatment at 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Seoul National University Hospital

Investigators

  • Principal Investigator: Won-Seok Kim, MD, PhD, Seoul National University Bundang Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 20, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

February 28, 2027

Study Registration Dates

First Submitted

April 3, 2026

First Submitted That Met QC Criteria

April 3, 2026

First Posted (Actual)

April 13, 2026

Study Record Updates

Last Update Posted (Actual)

April 15, 2026

Last Update Submitted That Met QC Criteria

April 12, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • B-2602-1027-304 (Other Identifier: Seoul National University Bundang Hospital)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Feasibility Studies

Clinical Trials on Home-based self-exercise feedback program using video

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe